US · biotech · healthcare · pharmaceutical

Who invested in Seaport Therapeutics

One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.

1
rounds observed
1
investors named
$225M
reported across those rounds
Oct 2024
most recent

The rounds

Series B · Oct 2024 · $225M

General Atlantic lead

Reported by Crunchbase News · SEC filing: $226M sold under the offering, first sale Oct 2024

Everyone who backed them

InvestorTypeRounds
Growth equity1

Missing a round, or an investor who was in one? Tell us.